Core Viewpoint - Sichuan Huazhu Turing Additive Manufacturing Technology Co., Ltd. has successfully completed a Pre-A round financing of several million RMB, led by Luzhou Aviation Development Group, aimed at enhancing product matrix research and development, accelerating the registration of core products as Class III medical devices, and expanding its commercial layout nationwide [1][4]. Company Overview - Established in 2018, Huazhu Turing is a national high-tech enterprise focused on providing comprehensive solutions for medical 3D printing, integrating research and development, manufacturing, sales, and services [3]. - The company aims to explore the applications of 3D printing in the medical field, with a strategic focus on brand building, innovation leadership, and comprehensive operational coverage [3]. Business Model and Strategy - Huazhu Turing has developed a new business model that combines the continuous development of innovative medical devices with the establishment of medical 3D printing centers, driving synchronized growth [3]. - The company collaborates with multiple medical institutions and universities to establish joint research centers for medical 3D printing, promoting innovation in medical device development and expanding clinical application scenarios [3]. Future Plans - The recent financing is seen as a recognition of the company's commitment to a "clinical value-driven" approach, with plans to convert capital into research and market competitiveness [4]. - Huazhu Turing aims to increase research and development investment, expand clinical application scenarios, and enhance the integration of industry, academia, and research to build a sustainable industrial ecosystem [4].